2020
DOI: 10.14573/altex.2001181
|View full text |Cite
|
Sign up to set email alerts
|

Modeling chemotherapy-induced peripheral neuropathy using a Nerve-on-a-chip microphysiological system

Abstract: CIPN), which is rapidly induced after the administration of anti-cancer drugs (Argyriou et al., 2012; Cavaletti and Marmiroli, 2010). Patients with CIPN may experience a range of sensory symptoms including spontaneous tingling, burning pain, and joint and muscle pain in the distal extremities in a "glove and stocking" distribution (Peters et al., 2007). Often, these side effects discourage patient use of the drug, leading to delays or limited dosages and even discontinued treatment altogether (Staff et al., 20… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
13
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 51 publications
2
13
0
Order By: Relevance
“…Compounds showing promise in animal experimental models of peripheral neuropathy may also fail in clinical settings. The nerve-on-a-chip model in this study utilized rat cells, and further development of microphysiological systems using human primary or iPSC-derived neurons might provide additional insights into species differences in outcomes ( Kramer et al, 2020 ). Lastly, further research is needed to test and verify the mechanisms by which dexanabinol elicits its effects on CIPN in vivo and whether these preclinical results will ultimately translate to human therapeutics.…”
Section: Discussionmentioning
confidence: 99%
“…Compounds showing promise in animal experimental models of peripheral neuropathy may also fail in clinical settings. The nerve-on-a-chip model in this study utilized rat cells, and further development of microphysiological systems using human primary or iPSC-derived neurons might provide additional insights into species differences in outcomes ( Kramer et al, 2020 ). Lastly, further research is needed to test and verify the mechanisms by which dexanabinol elicits its effects on CIPN in vivo and whether these preclinical results will ultimately translate to human therapeutics.…”
Section: Discussionmentioning
confidence: 99%
“…Kramer et al fabricated a lollipop-shaped container using dual hydrogels to develop a myelinated peripheral nerve model, as shown in Figure 5A ( Khoshakhlagh et al, 2018 ; Kramer et al, 2020 ). Neural cells and gliocytes are co-cultured in a spheroid microplate to form a cell sphere that will be moved to the circle part of the container.…”
Section: Advanced Models For Ex Vivo Non Studiesmentioning
confidence: 99%
“…These long-term culture conditions allow for extensive neurite outgrowth in all dimensions with growth-restrictive hydrogels being able to confine dense axon beds to specific areas for electrophysiological recordings. These constructs can then be used for electrophysiological assessment and exhibit peaks that are able to be defined by treatment with drugs (Kramer et al 2020). Additional to neuron function, glia are able to grow and myelinate, more on that next.…”
Section: D Peripheral Nerve Mpsmentioning
confidence: 99%
“…and 3D bioprinted substrates (Antill-O'Brien et al 2019) in order to recreate aspects of 3D macrostructure or neural connectivity seen in the brain. The peripheral nerve has also seen advancements in growing explant or spheroid cultures within anisotropic materials(Anderson et al 2018;George et al 2019) and growth restrictive hydrogels(Huval et al 2015;Nguyen et al 2019;Sharma et al 2019;Kramer et al 2020), respectively. Ultimately, the inherent qualities of anatomical histoarchitecture should guide the design of microarchitectural features of microphysiological devices.…”
mentioning
confidence: 99%